D'AMBROSIO, Lorenzo

D'AMBROSIO, Lorenzo  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 39 (tempo di esecuzione: 0.25 secondi).
Titolo Data di pubblicazione Autore(i) File
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. 2012 Grignani G; Palmerini E; Dileo P; Asaftei SD; D'Ambrosio L; Pignochino Y; Mercuri M; Picci P; Fagioli F; Casali PG; Ferrari S; Aglietta M.
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways 2012 Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G.
Alpha-fetoprotein elevation in NUT midline carcinoma: a case report 2017 D'Ambrosio, Lorenzo; Palesandro, Erica; Moretti, Marina; Pelosi, Giuseppe; Fabbri, Alessandra; Carnevale Schianca, Fabrizio; Aglietta, Massimo; Grignani, Giovanni
Anticoagulation for central venous catheters in patients with cancer. 2014 D'Ambrosio L;Aglietta M;Grignani G
Assessment of morphological CT imaging features for the prediction of risk stratification, mutations, and prognosis of gastrointestinal stromal tumors 2021 Cannella R.; Tabone E.; Porrello G.; Cappello G.; Gozzo C.; Incorvaia L.; Grignani G.; Merlini A.; D'Ambrosio L.; Badalamenti G.; Regge D.; Bartolotta T.V.
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells 2018 Leuci, V.; Casucci, G.M.; Grignani, G.; Rotolo, R.; Rossotti, U.; Vigna, E.; Gammaitoni, L.; Mesiano, G.; Fiorino, E.; Donini, C.; Pisacane, A.; ambrosio, L.D.; Pignochino, Y.; Aglietta, M.; Bondanza, A.; Sangiolo, D.
The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models 2013 Pignochino, Ymera; Dell'Aglio, Carmine; Basiricò, Marco; Capozzi, Federica; Soster, Marco; Marchiò, Serena; Bruno, Stefania; Gammaitoni, Loretta; Sangiolo, Dario; Torchiaro, Erica; D'Ambrosio, Lorenzo; Fagioli, Franca; Ferrari, Stefano; Alberghini, Marco; Picci, Piero; Aglietta, Massimo; Grignani, Giovanni
Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature. 2014 Rota Scalabrini D;Caravelli D;Carnevale Schianca F;D'Ambrosio L;Tolomeo F;Boccone P;Manca A;De Rosa G;Nuzzo A;Aglietta M;Grignani G
Complete Resolution of Life-Threatening Bleomycin-Induced Pneumonitis After Treatment With Imatinib Mesylate in a Patient With Hodgkin's Lymphoma: Hope for Severe Chemotherapy-Induced Toxicity? 2011 Carnevale-Schianca F; Gallo S; Rota-Scalabrini D; Sangiolo D; Fizzotti M; Caravelli D; Capaldi A; Anselmetti G; Palesandro E; D'Ambrosio L; Coha V; Obert R; Aglietta M; Grignani G.
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes 2020 Leuci, Valeria; Donini, Chiara; Grignani, Giovanni; Rotolo, Ramona; Mesiano, Giulia; Fiorino, Erika; Gammaitoni, Loretta; D'Ambrosio, Lorenzo; Merlini, Alessandra; Landoni, Elisa; Medico, Enzo; Capellero, Sonia; Giraudo, Lidia; Cattaneo, Giulia; Iaia, Ilenia; Pignochino, Ymera; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Fagioli, Franca; Ferrone, Soldano; Aglietta, Massimo; Gianpietro, Dotti; Sangiolo, Dario
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy 2018 Mesiano, Giulia; Grignani, Giovanni; Fiorino, Erika; Leuci, Valeria; Rotolo, Ramona; D'Ambrosio, Lorenzo; Salfi, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Pisacane, Alberto; Butera, Sara; Pignochino, Ymera; Basiricó, Marco; Capozzi, Federica; Sapino, Anna; Aglietta, Massimo; Sangiolo, Dario
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas. 2014 Sangiolo D; Mesiano G; Gammaitoni L; Leuci V; Todorovic M; Giraudo L; Cammarata C; Dell'aglio C; D'Ambrosio L; Pisacane A; Sarotto I; Miano S; Ferrero I; Carnevale-Schianca F; Pignochino Y; Sassi F; Bertotti A; Piacibello W; Fagioli F; Aglietta M; Grignani G.
Delving into PARP inhibition from bench to bedside and back 2020 Grignani G.; Merlini A.; Sangiolo D.; D'Ambrosio L.; Pignochino Y.
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group 2020 D'Ambrosio, Lorenzo; Touati, Nathan; Blay, Jean-Yves; Grignani, Giovanni; Flippot, Ronan; Czarnecka, Anna M; Piperno-Neumann, Sophie; Martin-Broto, Javier; Sanfilippo, Roberta; Katz, Daniela; Duffaud, Florence; Vincenzi, Bruno; Stark, Daniel P; Mazzeo, Filomena; Tuchscherer, Armin; Chevreau, Christine; Sherriff, Jenny; Estival, Anna; Litière, Saskia; Sents, Ward; Ray-Coquard, Isabelle; Tolomeo, Francesco; Le Cesne, Axel; Rutkowski, Piotr; Stacchiotti, Silvia; Kasper, Bernd; Gelderblom, Hans; Gronchi, Alessandro
Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomas 2021 Kantidakis, Georgios; Litière, Saskia; Neven, Anouk; Vinches, Marie; Judson, Ian; Schöffski, Patrick; Wardelmann, Eva; Stacchiotti, Silvia; D'Ambrosio, Lorenzo; Marréaud, Sandrine; van der Graaf, Winette T A; Kasper, Bernd; Fiocco, Marta; Gelderblom, Hans
Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma 2021 Giordano G.; Merlini A.; Ferrero G.; Mesiano G.; Fiorino E.; Brusco S.; Centomo M.L.; Leuci V.; D'ambrosio L.; Aglietta M.; Sangiolo D.; Grignani G.; Pignochino Y.
Eribulin-based treatment in patients affected by sarcomas: a case series 2020 Grignani, Giovanni; D'Ambrosio, Lorenzo
Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients 2017 Longhi, A; Bielack, S S; Grimer, R; Whelan, J; Windhager, R; Leithner, A; Gronchi, A; Biau, D; Jutte, P; Krieg, A H; Klenke, F M; Grignani, G; Donati, D M; Capanna, R; Casanova, J; Gerrand, C; Bisogno, G; Hecker-Nolting, S; De Lisa, M; D'Ambrosio, L; Willegger, M; Scoccianti, G; Ferrari, S
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series 2020 Palmerini E.; Setola E.; Grignani G.; D'Ambrosio L.; Comandone A.; Righi A.; Longhi A.; Cesari M.; Paioli A.; Hakim R.; Pierini M.; Marchesi E.; Vanel D.; Pignochino Y.; Donati D.M.; Picci P.; Ferrari S.
How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience 2017 Marchesi, Emanuela; Cagnazzo, Celeste; Quattrini, Irene; Leopardi, Martina Piccinni; Villa, Chiara; Grignani, Giovanni; D'Ambrosio, Lorenzo; Stacchiotti, Silvia; Casali, Paolo Giovanni; Picci, Piero